MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PHIO has $11,505K in assets. $1,666K in debts. $10,705K in cash and cash equivalents.

Balance Sheets Overview

Debt to Asset Ratio
14.48%
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Property and equipment, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
10,705 10,775
Prepaid expenses and other current assets
788 519
Total current assets
11,493 11,294
Property and equipment, net
12 7
Total assets
11,505 11,301
Accounts payable
516 235
Total current liabilities
-1,206
Accrued expenses
1,150 971
Total liabilities
1,666 1,206
Common stock, 0.0001 par value, 100,000,000 shares authorized 5,784,770 and 1,733,717 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
1 -
Additional paid-in capital
162,521 160,386
Accumulated deficit
-152,683 -150,291
Total stockholders' equity
9,839 10,095
Total liabilities and stockholders' equity
11,505 11,301
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$788K Cash and cashequivalents$10,705K Property and equipment,net$12K Total current assets$11,493K Total assets$11,505K Total liabilities andstockholders' equity$11,505K Total stockholders'equity$9,839K Total liabilities$1,666K Accumulated deficit-$152,683K Additional paid-in capital$162,521K Accrued expenses$1,150K Accounts payable$516K Common stock, 0.0001par value,...$1K

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp. (PHIO)